The U.S. Food and Drug Administration (FDA) has announced that Medtronic is recalling 87,709 implantable cardiac devices due to the risk of a malfunction that could result in serious injury or death. …

CathVision, a Denmark-based healthcare technology company focused on the electrophysiology (EP) lab, has closed a new financing round worth $7.2 million. The funding…

Monitoring patient symptoms is an essential part of diagnosing and treating cardiovascular disease (CVD). A new scientific statement from the American Heart Association (AHA), published in Circulation…

Atrial cardiomyopathy is associated with an increased risk of dementia among older adults, according to new research published in the Journal of the American Heart Association.[1]

“Stroke and atrial fibrillation (AFib) are two…

In a massive simulation exercise, researchers recently found that using wrist-worn wearable devices to screen people for atrial fibrillation (AFib) may be more cost-effective than traditional modalities such as pulse palpation and 12-…

The risk of in-hospital mortality may be significantly higher among transcatheter edge-to-edge repair (TEER) patients who present with concomitant…

There is not agreement among some of the top structural heart experts who perform left atrial appendage occlusion (LAAO) if cardiac computed tomography (CT…

The U.S. Food and Drug Administration (FDA) has had a busy in July, approving Eko’s…

Patients with heart failure or…

The KardiaBand device from AliveCor is a more reliable tool for identifying atrial fibrillation (AFib) than the…

Patients with a history of atrial fibrillation (AFib) are more likely to experience adverse outcomes within two years of transcatheter aortic valve…

When the first catheter-implanted, leadless pacemaker was introduced in 2016, there was a lot of interest in this minimally invasive technology. But the biggest criticism was that it only addressed the needs of about 20% of patients. However, 100…

Catheter ablation is an "economically attractive" treatment option for atrial fibrillation (AFib) when compared to antiarrhythmic drug therapy alone,, according to a new study in Circulation.[1] 

While the lifetime cost of…

Patients who develop atrial fibrillation (AFib) after surgery face a higher risk of being hospitalized for heart failure, according to new data published in the European Heart Journal.[1]

The study’s authors tracked data from…

Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller…

Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology.[1]

“Marijuana is widely used across the…

Non-vitamin K antagonist oral anticoagulants (NOACs) may be a safe alternative to warfarin when treating patients with atrial fibrillation (AFib) and valvular heart disease (VHD), according to new research published in the American Journal of…

inHEART Medical, an international healthcare company with offices in France and the United States, has received clearance from the U.S. Food and Drug Administration (FDA) for its new 3D visualization software…

Left bundle branch block (LBBB), one of the most common complications after transcatheter aortic valve replacement (TAVR), is associated with worse…

It has been a busy few weeks for the U.S. Food and Drug Administration (FDA). The agency…